Month: September 2021

Partners Leverage Qatalyst to Solve Customers’ Complex Problems Now, with Minimal Investment in Quantum Expertise LEESBURG, Va., Sept. 14, 2021 (GLOBE NEWSWIRE) — Quantum Computing Inc. (the “company” or “QCI”) (Nasdaq: QUBT) today announced the QCI Partner Program, giving partners first mover advantage by offering a low risk, high reward path to utilize quantum computing to solve critical optimization problems for their customers. With QCI and Qatalyst™, program partners offer a seamless bridge to unleash the power of quantum technology for government and business sectors to propel customer value, as they fuel their own financial results. QCI partners leverage Qatalyst to accelerate their customers’ time-to-quantum results. It’s an ideal solution for customers that require complex optimization to improve decision-making, providing...

UBN ACTIVATE™UBN ACTIVATE™ is clinically proven to enhance brain function, improve cognition, memory, focus, and mood while supporting natural sleep patterns at night.LAS VEGAS, Sept. 14, 2021 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, announced a pilot study was recently published in Annals of Reviews and Research highlighting the ability of its Ultimate Brain Nutrients™ (UBN™) ACTIVATE™ to naturally increase key brain activity by as much as 46%. The article titled, A Phytonutrient Based Brain Activation Complex and Short-Term Brain Function Changes: An Initial Investigation, describes how the consumption of ACTIVATE can dramatically improve human cognitive behavior and mental focus by activating areas of the...

LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that it will be presenting at the Oppenheimer Fall Healthcare Summit being held virtually September 20-23, 2021. Jan D’Alvise, President and Chief Executive Officer of Acasti Pharma, is scheduled to present on Tuesday, September 21, 2021 at 2:05 PM Eastern Time. Management will also be participating in one-on-one meetings with qualified members of the investor community throughout the conference. Oppenheimer Fall Healthcare Life Sciences & MedTech Summit will feature presentations and one-on-one meetings in a virtual format with a select group of public companies in the Healthcare Life Sciences and MedTech arena. Contact your Oppenheimer sales representative or Financial Professional...

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of indications, today announced that Angelos Stergiou, MD, ScD. h.c., President and Chief Executive Officer of SELLAS, will present at the 2021 Cantor Global Healthcare Conference to be held virtually on Tuesday, September 28, 2021, at 4:00 p.m. ET. For more information about the conference, or to schedule a one-on-one meeting with SELLAS management, please contact your Cantor representative directly, or send an email to Cantor at corporateaccess@cantor.com or KCSA Strategic Communications at SELLAS@kcsa.com. About SELLAS Life Sciences Group, Inc. SELLAS is a late-stage clinical biopharmaceutical...

Data from Three New Studies and Two Ongoing Trials Presented at the Heart Failure Society of America Annual Scientific Meeting 2021 Data Highlight Importance of Blood Volume Analysis in Providing Appropriate, Personalized Care to Patients with Heart Failure Oak Ridge, TN, Sept. 14, 2021 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 blood test in optimizing individualized therapy for heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2021 – which brought together the world’s leading experts in heart failure from September 10-13, 2021, in Denver, CO. “We continue to add to the clinical evidence demonstrating that the BVA-100...

MISSISSAUGA, Ontario, Sept. 14, 2021 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX: GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services, announced today that the Company has ranked 7th on the TSX30 list. The TSX30 ranks the 30 top-performing stocks on the Toronto Stock Exchange, Canada’s premier equities market, based on dividend-adjusted share price appreciation over a three-year period. This is goeasy’s second time ranking on the TSX30 since it was introduced in 2019. “We are proud to be ranked as a top performing Canadian company, with cumulative three-year dividend-adjusted share price appreciation of 327%,” said Jason Mullins, goeasy’s President and Chief Executive Officer. “Ranking 7th on the TSX over the last 3 years truly demonstrates the strength and resiliency of our business...

Increased sales result in 57% revenue growth for another record-setting quarter. Mississauga, Ontario, Sept. 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Skkynet Cloud Systems, Inc. (“Skkynet” or “the Company”) (OTCQB: SKKY) is pleased to announce its quarter-end operating and financial results for the period ended July 31, 2021.  The Company reported a record third quarter revenue of $497,375 compared to $316,918 for the same period in 2020, which marks a 57% growth in sales.  Net loss from operations for the 3-month period was $15,490 compared to a net loss of $60,784 for the same period in 2020.  The Company reported a record nine month revenue total of $1,383,414 compared to $1,155,443 for the same period in 2020, which is a 20% growth in sales. “Skkynet’s Q3 2021 results are in line with our expectations, and positive...

SHOUGUANG, China, Sept. 14, 2021 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources”, “we”, or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today provides net revenue and net income guidance for the 3rd Quarter and full year of 2021. All estimates provided below are based on the current outlook and all exclude unexpected nonrecurring and non-operational factors. In the 3rd Quarter 2021, the price of bromine has declined slightly from the record levels of the second quarter but is still near historic levels. Based on the production levels through the first two months and one week of the quarter, the company currently expects net revenues of between $16.2 and $16.7 million. This compares to net revenues of $11.1 million...

NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider in China, today announced that it entered into a Stock Purchase Agreement (the “Agreement”) on September 10, 2021, to acquire Chongqing Zhuoda Pharmaceutical Co., Ltd. (“Zhuoda”), a wholesale supplier of pharmaceuticals and medical equipment, including over 1,220 pharmaceutical products, thousands of Chinese herbal medicines and more than 50 types of medical equipment.Pursuant to the Agreement, BIMI will purchase all the issued and outstanding equity interests in Zhuoda in consideration of US$11,617,500 (RMB 75,000,000). At the closing, 2,200,000 shares of common stock of BIMI valued at RMB 43,560,000, or $3.00 per share (approximately US$6,600,000) will be...